Application of ATP Infusions in Palliative Home Care
Status and phase
Conditions
Treatments
Details and patient eligibility
About
Palliative care in cancer aims at alleviating the suffering of patients. A previous study in patients with advanced non-small-cell lung cancer showed that adenosine 5'-triphosphate (ATP) infusions had a favourable effect on fatigue, appetite, body weight, muscle strength, functional status, quality of life, and survival. Based on these promising results, the present study was designed 1. To evaluate whether the beneficial effects of ATP administration observed in patients with advanced lung cancer would also be present in pre-terminal cancer patients of different tumour types, and 2. To test the feasibility of application of ATP infusions in a home care setting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- cytologically or histologically confirmed cancer
- medical treatment options restricted to supportive care
- a life expectancy < 6 months
- World Health Organization (WHO) performance status 1 or 2
- suffering from at least one of the following complaints: fatigue, weight loss > 5% over the last 6 months, or anorexia
Exclusion criteria
- symptomatic angina pectoris
- symptomatic heart failure
- any form of atrioventricular (AV) block (assessed by electrocardiogram)
- life expectancy < 4 weeks
- concurrent palliative chemotherapy
- cognitive dysfunction, and other diseases hampering adequate follow up
Trial design
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal